4
Changes in Ownership
ALX ONCOLOGY HOLDINGS INC Filed Acc 0001415889-24-004210
CHIEF EXECUTIVE OFFICER acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lettmann Jason CHIEF EXECUTIVE OFFICER | 2024-02-14 | Grant or award | +60,000 | 167,220 | D | ||
| Derivatives | |||||||
| Lettmann Jason CHIEF EXECUTIVE OFFICER | 2024-02-14 | Grant or award · Employee Stock Option | +190,000 | 190,000 | D | ||
Loading xslF345X05/form4-02162024_110246.xml…